clarithromycin 500 mg/1
clarithromycin · TABLET, FILM COATED, EXTENDED RELEASE · Actavis Pharma, Inc.
Clarithromycin is a macrolide antibiotic used to treat various bacterial infections, including respiratory tract infections, skin infections, and certain stomach ulcers caused by H. pylori bacteria. This extended-release tablet form is taken by mouth and allows for less frequent dosing compared to immediate-release versions.
Key Facts
- Brand Name
- clarithromycin
- Generic Name
- clarithromycin
- NDC Code (Product)
0591-2805- Manufacturer
- Actavis Pharma, Inc.
- Strength
- 500 mg/1
- Dosage Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA065145
- Drug Class
- Macrolide Antimicrobial [EPC]
- Marketing Start
- 02/27/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is clarithromycin used for?
Clarithromycin is a macrolide antibiotic used to treat various bacterial infections, including respiratory tract infections, skin infections, and certain stomach ulcers caused by H. pylori bacteria. This extended-release tablet form is taken by mouth and allows for less frequent dosing compared to immediate-release versions.
Is clarithromycin a controlled substance?
clarithromycin is not classified as a controlled substance by the DEA.
What is the generic name for clarithromycin?
The generic name for clarithromycin is clarithromycin. There are 12 other brand versions of clarithromycin.
What is the NDC code for clarithromycin 500 mg/1?
The NDC (National Drug Code) for clarithromycin 500 mg/1 is 0591-2805, listed by Actavis Pharma, Inc..
Other Clarithromycin Brands
See all →- Clarithromycin500 mg/185766-198
- Clarithromycin500 mg/143063-752
- Clarithromycin250 mg/146708-344
- Clarithromycin500 mg/150090-1830
- CLARITHROMYCIN250 mg/162135-616
- Clarithromycin500 mg/168002-104
- Clarithromycin500 mg/168071-5045
- Clarithromycin500 mg/10527-1930
- Clarithromycin500 mg/10527-1932
- Clarithromycin500 mg/173473-911
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)